The IVI’s Health Equity Initiative is a two-year effort aimed at advancing multi-stakeholder dialogue about best practices and opportunities for meaningful change in the valuation of health care to recognize diversity, address existing health disparities, and promote equitable access to care. In order to achieve the primary goals of the initiative, IVI scientific leadership is heading a series of activities, guided by a collaborative, expert steering group and with facilitated input from a select group of invited methods and research experts. This multidisciplinary body brings expertise in health equity and disparities, clinical comparative effectiveness and patient preference research, HEOR methods, value assessment/health technology assessment, and data collection and analytics. In addition, user communities, including payers, purchasers, and employers, will be key participants. Stakeholder communities of color – especially patients, patient advocacy, and care providers will help lead the committee in this initiative.

Committee Members

Tammy Boyd, JD, MPH

American Cancer Society, Cancer Action Network

Vakaramoko Diaby, PhD, MSc, CRA


Amy Duhig, PhD


Judith Flores, MD, FAAP, CHCQM

New York City Health + Hospitals/Woodhull

Nelly Ganesan, MPH

JPMorgan Chase – Morgan Health

Karen Mancera-Cuevas, DrPH, MPH, MS

National Health Council

Pierluigi Mancini, PhD

Multicultural Development Institute

Jacquelyn McRae, PharmD, MS


Eberechukwu Onukwugha, PhD, MS (March 2022 – May 2023)

University of Maryland, School of Pharmacy

Lauren Powell, PhD, MPA (March 2022 – March 2023)

Takeda Pharmaceuticals (Formerly)

Jacob Quinton, MD, MSHS, FACP (March 2022 – April 2023)

Center for Medicare and Medicaid Innovation

Charlene Son Rigby, MBA

Global Genes

Bonnie Swenor, PhD, MPH

Johns Hopkins Bloomberg School of Public Health

Ashley Valentine, MRes

Sick Cells